TcoF overview
| TcoF: | ELL3 | |
| GeneID: | 80314 | |
| Name: | RNA polymerase II elongation factor ELL3 | |
| Ensembl: | ENSG00000128886 | |
| Species: | Human | |
| Class: | class HC | |
| Family: | GTF | |
| Disease: | 0 | |
| Go term: | 17 | |
| Pathway: | 1 | |
| Hallmark: | 2 | |
| Super Enhancer: |
-- |
|
| Enhancer: |
chr15:44084810-44085170 chr15:44061840-44062440 chr15:44085280-44085770 chr15:44099570-44101950 chr15:44102110-44104240 chr15:43985300-43986070 chr15:43986400-43987000 chr15:44290120-44292020 chr15:44292180-44293030 chr15:44451630-44452280 chr15:44449040-44451410 chr15:44027180-44028040 chr15:43928020-43928230 chr15:44014110-44014690 chr15:44221210-44223330 chr15:44235320-44236650 chr15:44246180-44247070 chr15:44250720-44251890 chr15:44326550-44328820 chr15:44357480-44359600 chr15:44373420-44374230 chr15:44379600-44381200 chr15:44391180-44392460 chr15:44484220-44486420 chr15:44499330-44501150 chr15:44506760-44508730 chr15:44632150-44634370 chr15:44300670-44303050 chr15:44308420-44309930 chr15:43958360-43959750 chr15:43932720-43933350 chr15:43998280-43999800 chr15:44029210-44031090 chr15:44044750-44046020 chr15:44137680-44138620 chr15:44054840-44055270 chr15:44153240-44153530 chr15:44055400-44056720 chr15:43330080-43330360 chr15:43330430-43332330 chr15:44046100-44047440 chr15:44213730-44215490 chr15:44219380-44221170 chr15:44269150-44270110 |
|
| Promoter: |
chr15:44064803-44069513 |
ChIP-seq based regulatory details of ELL3
| Sample ID | Experiment target | Biosample type | Biosample term name | GSM ID | Tissue type | Source |
|---|
Downstream target genes of ELL3
Upstream regulatory details of ELL3
Protein-protein interaction of ELL3
| OFFICIAL_SYMBOL_A | OFFICIAL_SYMBOL_B | EXPERIMENTAL_SYSTEM | PUBMED_ID | ORGANISM_A_ID | ORGANISM_B_ID | SOURCE |
|---|---|---|---|---|---|---|
| ELL3 | FTH1 | Two-hybrid | 16169070 | 9606 | 9606 | BIOGRID |
| ELL3 | ICE2 | Affinity Capture-MS | 26186194 | 9606 | 9606 | BIOGRID |
| ELL3 | AFF1 | Affinity Capture-MS | 26186194 | 9606 | 9606 | BIOGRID |
| ELL3 | ICE1 | Affinity Capture-MS | 26186194 | 9606 | 9606 | BIOGRID |
| ELL3 | MLLT3 | Affinity Capture-MS | 26186194 | 9606 | 9606 | BIOGRID |
| ELL3 | MLLT1 | Affinity Capture-MS | 26186194 | 9606 | 9606 | BIOGRID |
| ELL3 | EAF2 | Affinity Capture-MS | 26186194 | 9606 | 9606 | BIOGRID |
| ELL3 | ADD3 | Affinity Capture-MS | 26186194 | 9606 | 9606 | BIOGRID |
| ELL3 | CCNT2 | Affinity Capture-MS | 26186194 | 9606 | 9606 | BIOGRID |
| ELL3 | CCNT1 | Affinity Capture-MS | 26186194 | 9606 | 9606 | BIOGRID |
| ELL3 | CDK14 | Affinity Capture-MS | 26186194 | 9606 | 9606 | BIOGRID |
| ELL3 | ELL | Affinity Capture-MS | 26186194 | 9606 | 9606 | BIOGRID |
| ELL3 | MLLT1 | Affinity Capture-MS | 28514442 | 9606 | 9606 | BIOGRID |
| ELL3 | ICE1 | Affinity Capture-MS | 28514442 | 9606 | 9606 | BIOGRID |
| ELL3 | AFF1 | Affinity Capture-MS | 28514442 | 9606 | 9606 | BIOGRID |
| ELL3 | ICE2 | Affinity Capture-MS | 28514442 | 9606 | 9606 | BIOGRID |
| ELL3 | MLLT3 | Affinity Capture-MS | 28514442 | 9606 | 9606 | BIOGRID |
| ELL3 | CCNT1 | Affinity Capture-MS | 28514442 | 9606 | 9606 | BIOGRID |
| ELL3 | CDK14 | Affinity Capture-MS | 28514442 | 9606 | 9606 | BIOGRID |
| ELL3 | CCNT2 | Affinity Capture-MS | 28514442 | 9606 | 9606 | BIOGRID |
| ELL3 | ELL | Affinity Capture-MS | 28514442 | 9606 | 9606 | BIOGRID |
| ELL3 | EAF2 | Affinity Capture-MS | 28514442 | 9606 | 9606 | BIOGRID |
| ELL3 | ADD3 | Affinity Capture-MS | 28514442 | 9606 | 9606 | BIOGRID |
| ELL3 | EAF1 | Two-hybrid | 32296183 | 9606 | 9606 | BIOGRID |
Annotation of ELL3
TCGA cancer survival map of ELL3
Expression of ELL3
Disease information of ELL3